Why does obesity promote cancer? Epidemiology, biology, and open questions

ecancermedicalscience

Volumn 9, Issue , 2015, Pages

  Mazzarella, Luca ^a  

^a EUROPEAN INSTITUTE OF ONCOLOGY   (Italy)

Author keywords

Body mass index; DNA damage; Inflammation; Insulin; Obesity

Indexed keywords

ESTROGEN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; INSULIN; METFORMIN; SOMATOMEDIN C;

ANTHROPOMETRIC PARAMETERS; BODY FAT; BODY MASS; BREAST CANCER; CANCER MORTALITY; CANCER RISK; COLORECTAL CANCER; EPIDEMIC; FEMALE GENITAL TRACT CANCER; HUMAN; INFLAMMATION; LIFESTYLE MODIFICATION; LIVER CANCER; METABOLIC SYNDROME X; NONHUMAN; OBESITY; REVIEW;

EID: 84938685746     PISSN: None     EISSN: 17546605     Source Type: Journal    
DOI: 10.3332/ecancer.2015.554     Document Type: Review

References (109)

1. Ogden CL et al (2014) Prevalence of childhood and adult obesity in the United States, 2011-2012 JAMA 311(8) 806-14 DOI: 10.1001/jama.2014.732 PMID: 24570244
2. Parkin DM, Boyd L and Walker LC (2011) The fraction of cancer attributable to lifestyle and environmental factors in the UK in 2010 Br J Cancer 105(Suppl 2) S77-S81 DOI: 10.1038/bjc.2011.489
3. Arnold M et al (2015) Global burden of cancer attributable to high body-mass index in 2012: a population-based study Lancet Oncol 16(1) 36-46 DOI: 10.1016/s1470-2045(14)71123-4
4. Waxler SH et al (1953) Obesity and the time of appearance of spontaneous mammary carcinoma in C3H mice Cancer Res 13(3) 276-8 PMID: 13042818
5. Waxler SH and Leef MF (1966) Augmentation of mammary tumors in castrated obese C3H Mice Cancer Res 26(5) 860-2 PMID: 5934796
6. de Waard F, Halewijn EABV and Huizinga J (1964) The bimodal age distribution of patients with mammary carcinoma. Evidence for the existence of 2 types of human breast cancer Cancer 17 141-51 DOI: 10.1002/1097-0142(196402)17:2<141::AID-CNCR2820170202>3.0.CO;2-Z PMID: 14123673
7. Bhaskaran K et al Body-mass index and risk of 22 specific cancers: a population-based cohort study of 5.24 million UK adults Lancet 384(9945) 755-65 DOI: 10.1016/s0140-6736(14)60892-8 PMID: 25129328 PMCID: 4151483
8. Calle EE et al (2003) Overweight, obesity, and nortality from cancer in a prospectively studied cohort of U.S. adults New Engl J Med 348(17) 1625-38 DOI: 10.1056/NEJMoa021423 PMID: 12711737
9. Flegal KM et al (2005) Excess deaths associated with underweight, overweight, and obesity JAMA 293(15) 1861-7 DOI: 10.1001/jama.293.15.1861 PMID: 15840860
10. Morimoto LM et al (2002) Obesity, body size, and risk of postmenopausal breast cancer: the Women's Health Initiative (United States) Cancer Causes Control 13(8) 741-51 DOI: 10.1023/A:1020239211145 PMID: 12420953
11. Renehan AG et al (2008) Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies Lancet 371(9612) 569-78 DOI: 10.1016/S0140-6736(08)60269-X PMID: 18280327
12. Ritte R et al (2012) Adiposity, hormone replacement therapy use and breast cancer risk by age and hormone receptor status: a large prospective cohort study Breast Cancer Res 14(3) R76 DOI: 10.1186/bcr3186 PMID: 22583394 PMCID: 3446339
13. Thiebaut AC et al (2007) Dietary fat and postmenopausal invasive breast cancer in the National Institutes of Health-AARP diet and health study cohort J Natl Cancer Inst 99 451-62 DOI: 10.1093/jnci/djk094 PMID: 17374835
14. Romero-Corral A et al (2008) Accuracy of body mass index to diagnose obesity in the US adult population Intl J Obes (2005) 32(6) 959-66 DOI: 10.1038/ijo.2008.11
15. Physical status: the use and interpretation of anthropometry Report of a WHO Expert Committee Report No. 0512-3054 (1995) (Print) 0512-3054 (Linking) 1-452
16. Breccia M et al (2012) Increased BMI correlates with higher risk of disease relapse and differentiation syndrome in patients with acute promyelocytic leukemia treated with the AIDA protocols Blood 119(1) 49-54 DOI: 10.1182/blood-2011-07-369595
17. Whitlock G et al (2009) Body-mass index and cause-specific mortality in 900 000 adults: collaborative analyses of 57 prospective studies Lancet 373(9669) 1083-1096 DOI: 10.1016/S0140-6736(09)60318-4 PMID: 19299006 PMCID: 2662372
18. Chan DS et al (2014) Body mass index and survival in women with breast cancer-systematic literature review and meta-analysis of 82 follow-up studies Ann Oncol 25(10) 1901-14 DOI: 10.1093/annonc/mdu042 PMID: 24769692 PMCID: 4176449
19. Gosse MA (2014) How accurate is self-reported BMI? Nutr Bulletin 39 105-114 DOI: 10.1111/nbu.12075
20. Suzuki R et al (2009) Body weight and incidence of breast cancer defined by estrogen and progesterone receptor status - a meta-analysis Int J Cancer 124(3) 698-712 DOI: 10.1002/ijc.23943
21. Potischman N (1996) Reversal of relation between body mass and endogenous estrogen concentrations with menopausal status J Natl Cancer Inst 88(11) 756-8 DOI: 10.1093/jnci/88.11.756 PMID: 8637031
22. Key TJ (2013) Sex hormones and risk of breast cancer in premenopausal women: a collaborative reanalysis of individual participant data from seven prospective studies Lancet Oncol 14(10) 1009-19 DOI: 10.1016/S1470-2045(13)70301-2 PMID: 23890780 PMCID: 4056766
23. Ewertz M et al (2010) Effect of Obesity on Prognosis After Early-Stage Breast Cancer J Clin Oncol 29(1) 25-31 DOI: 10.1200/JCO.2010.29.7614 PMID: 21115856
24. Pfeiler G et al (2011) Impact of body mass index on the efficacy of endocrine therapy in premenopausal patients with breast cancer: an analysis of the prospective ABCSG-12 trial J Clin Oncol 29(19) 2653-9 DOI: 10.1200/JCO.2010.33.2585 PMID: 21555684
25. Sestak I et al (2010) Effect of body mass index on recurrences in tamoxifen and anastrozole treated women: an exploratory analysis from the ATAC trial J Clin Oncol 28(21) 3411-5 DOI: 10.1200/JCO.2009.27.2021 PMID: 20547990
26. Mazzarella L et al (2013) Obesity increases the incidence of distant metastases in oestrogen receptor-negative human epidermal growth factor receptor 2-positive breast cancer patients Eur J Cancer 49(17) 3588-97 DOI: 10.1016/j.ejca.2013.07.016 PMID: 23953055
27. Birks S et al (2012) A systematic review of the impact of weight loss on cancer incidence and mortality Obes Rev 13(10) 868-91 DOI: 10.1111/j.1467-789X.2012.01010.x PMID: 22672203
28. Pischon T et al (2006) Body size and risk of colon and rectal cancer in the European Prospective Investigation Into Cancer and Nutrition (EPIC) J Natl Cancer Inst 98(13) 920-31 DOI: 10.1093/jnci/djj246 PMID: 16818856
29. Steins Bisschop CN et al (2014) Weight change later in life and colon and rectal cancer risk in participants in the EPIC-PANA-CEA study Am J Clin Nutr 99(1) 139-147 DOI: 10.3945/ajcn.113.066530
30. Parkin E et al (2014) Excess adiposity and survival in patients with colorectal cancer: a systematic review Obes Rev 15(5) 434-51 DOI: 10.1111/obr.12140 PMID: 24433336
31. Wu S et al (2014) Association of obesity and overweight with overall survival in colorectal cancer patients: a meta-analysis of 29 studies Cancer Causes Control 25(11) 1489-1502 DOI: 10.1007/s10552-014-0450-y PMID: 25070668
32. Crosbie EJ et al (2010) Body mass index, hormone replacement therapy, and endometrial cancer risk: a meta-analysis Cancer Epidemiol Biomarkers Prev 19(12) 3119-30 DOI: 10.1158/1055-9965.EPI-10-0832 PMID: 21030602
33. Dunn LJ et al (1968) Glucose tolerance and endometrial carcinoma: A controlled study Arch Intern Med 121(3) 246-54 DOI: 10.1001/archinte.1968.03640030038006 PMID: 4868282
34. Luo J et al (2014) Association between diabetes, diabetes treatment and risk of developing endometrial cancer Br J Cancer 111(7) 1432-9 DOI: 10.1038/bjc.2014.407 PMID: 25051408 PMCID: 4183842
35. Arem H and Irwin ML (2013) Obesity and endometrial cancer survival: a systematic review Int J Obes (Lond) 37(5) 634-9 DOI: 10.1038/ijo.2012.94
36. Arem H et al (2013) Body mass index, physical activity, and survival after endometrial cancer diagnosis: results from the Women's Health Initiative Gynecol Oncol 128(2) 181-6 DOI: 10.1016/j.ygyno.2012.10.029 PMCID: 3552067
37. Arem H et al (2013) Prediagnosis body mass index, physical activity, and mortality in endometrial cancer patients J Natl Cancer Inst 105(5) 342-9 DOI: 10.1093/jnci/djs530 PMID: 23297041 PMCID: 3589256
38. El-Serag HB and Kanwal F (2014) Epidemiology of hepatocellular carcinoma in the United States: where are we? Where do we go? Hepatology 60(5) 1767-75 DOI: 10.1002/hep.27222 PMID: 24839253 PMCID: 4211957
39. Baffy G, Brunt EM and Caldwell SH (2012) Hepatocellular carcinoma in non-alcoholic fatty liver disease: an emerging menace J Hepatol 56 1384-91 DOI: 10.1016/j.jhep.2011.10.027 PMID: 22326465
40. Leung C et al (2015) Characteristics of hepatocellular carcinoma in cirrhotic and non-cirrhotic non-alcoholic fatty liver disease World J Gastroenterol 21(4) 1189-96 DOI: 10.3748/wjg.v21.i4.1189 PMID: 25632192 PMCID: 4306163
41. Franckhauser S et al (2002) Increased fatty acid re-esterification by PEPCK overexpression in adipose tissue leads to obesity without insulin resistance Diabetes 51(3) 624-30 DOI: 10.2337/diabetes.51.3.624 PMID: 11872659
42. Cooke MS et al (2003) Oxidative DNA damage: mechanisms, mutation, and disease FASEB J 17(10) 1195-214 DOI: 10.1096/fj.02-0752rev PMID: 12832285
43. Gates KS (2009) An overview of chemical processes that damage cellular DNA: spontaneous hydrolysis, alkylation, and reactions with radicals Chem Res Toxicol 22(11) 1747-60 DOI: 10.1021/tx900242k PMID: 19757819 PMCID: 2806061
44. Ayala A, Munoz MF and Arguelles S (2014) Lipid peroxidation: production, metabolism, and signaling mechanisms of malondialdehyde and 4-hydroxy-2-nonenal Oxid Med Cell Longev 22(11) 1747-60 360438 DOI: 10.1155/2014/360438
45. Niedernhofer LJ et al (2003) Malondialdehyde, a product of lipid peroxidation, is mutagenic in human cells J Biol Chem 278(33) 31426-33 DOI: 10.1074/jbc.M212549200 PMID: 12775726
46. Wang M et al (1996) Lipid peroxidation-induced putative malondialdehyde-DNA adducts in human breast tissues Cancer Epidemiol Biomarkers Prev 5(9) 705-10 PMID: 8877062
47. Long EK, Olson DM and Bernlohr DA (2013) High-fat diet induces changes in adipose tissue trans-4-oxo-2-nonenal and trans-4-hydroxy-2-nonenal levels in a depot-specific manner Free Radic Biol Med 63 390-8 DOI: 10.1016/j.freeradbiomed.2013.05.030 PMID: 23726997 PMCID: 3737572
48. Singh SP et al (2008) Role of the electrophilic lipid peroxidation product 4-hydroxynonenal in the development and maintenance of obesity in mice Biochemistry 47(12) 3900-11 DOI: 10.1021/bi702124u PMID: 18311940
49. Akingbade D et al (2012) Selection of monoclonal antibodies against 6-oxo-M(1)dG and their use in an LC-MS/MS assay for the presence of 6-oxo-M(1)dG in vivo Chem Res Toxicol 25(2) 454-61 DOI: 10.1021/tx200494h PMID: 22211372 PMCID: 3285145
50. Bielas JH and Heddle JA (2000) Proliferation is necessary for both repair and mutation in transgenic mouse cells Proc Natl Acad Sci USA 97(21) 11391-6 DOI: 10.1073/pnas.190330997 PMID: 11005832 PMCID: 17210
51. Gattinoni L et al (2011) A human memory T cell subset with stem cell-like properties Nat Med 17(10) 1290-7 DOI: 10.1038/nm.2446 PMID: 21926977 PMCID: 3192229
52. Tomasetti C and Vogelstein B (2015) Cancer etiology. Variation in cancer risk among tissues can be explained by the number of stem cell divisions Science 347(6217) 78-81 DOI: 10.1126/science.1260825 PMID: 25554788 PMCID: 4446723
53. Ito K et al (2012) A PML-PPAR-delta pathway for fatty acid oxidation regulates hematopoietic stem cell maintenance Nat Med 18(9) 1350-8 DOI: 10.1038/nm.2882 PMID: 22902876 PMCID: 3566224
54. Mihaylova MM Sabatini DM and Yilmaz OH (2014) Dietary and metabolic control of stem cell function in physiology and cancer Cell Stem Cell 14(3) 292-305 DOI: 10.1016/j.stem.2014.02.008 PMID: 24607404 PMCID: 3992244
55. Iyengar NM, Hudis CA and Dannenberg AJ (2015) Obesity and cancer: local and systemic mechanisms Annu Rev Med 66 297-309 DOI: 10.1146/annurev-med-050913-022228 PMID: 25587653
56. Khandekar MJ, Cohen P and Spiegelman BM (2011) Molecular mechanisms of cancer development in obesity Nat Rev Cancer 11(12) 886-95 DOI: 10.1038/nrc3174 PMID: 22113164
57. Cleary MP and Grossmann ME (2009) Minireview: obesity and breast cancer: the estrogen connection Endocrinology 150(6) 2537-42 DOI: 10.1210/en.2009-0070 PMID: 19372199 PMCID: 2689796
58. Simpson ER (2004) Aromatase: biologic relevance of tissue-specific expression. Semin Reprod Med 22(1) 11-23 DOI: 10.1055/s-2004-823023 PMID: 15083377
59. Tchernof A et al (2015) Updated survey of the steroid-converting enzymes in human adipose tissues. J Steroid Biochem Mol Biol 147 56-69 DOI: 10.1016/j.jsbmb.2014.11.011
60. Subbaramaiah K et al (2011) Obesity is associated with inflammation and elevated aromatase expression in the mouse mammary gland Cancer Prev Res (Phila) 4(3) 329-46 DOI: 10.1158/1940-6207.CAPR-10-0381
61. Pollak M (2012) The insulin and insulin-like growth factor receptor family in neoplasia: an update Nat Rev Cancer 12(3) 159-169 DOI: 10.1038/nrc3215 PMID: 22337149
62. Olefsky JM and Glass CK (2010) Macrophages, inflammation, and insulin resistance Annu Rev Physiol 72 219-46 DOI: 10.1146/annurev-physiol-021909-135846 PMID: 20148674
63. Talukdar S et al (2012) Neutrophils mediate insulin resistance in mice fed a high-fat diet through secreted elastase Nat Med 18(9) 1407-12 DOI: 10.1038/nm.2885 PMID: 22863787 PMCID: 3491143
64. Anzo M et al (2008) Targeted deletion of hepatic Igf1 in TRAMP mice leads to dramatic alterations in the circulating insulin-like growth factor axis but does not reduce tumor progression Cancer Res 68(9) 3342-9 DOI: 10.1158/0008-5472.CAN-07-3165 PMID: 18451161 PMCID: 2928555
65. Baserga R (1995) The Insulin-like growth factor I receptor: A key to tumor growth? Cancer Res 55(2) 249-52 PMID: 7812953
66. Sprynski AC et al (2009) The role of IGF-1 as a major growth factor for myeloma cell lines and the prognostic relevance of the expression of its receptor Blood 113(19) 4614-26 DOI: 10.1182/blood-2008-07-170464 PMID: 19228610 PMCID: 2691749
67. Renehan AG et al (2012) Diabetes and cancer (2): evaluating the impact of diabetes on mortality in patients with cancer Diabetologia 55(6) 1619-32 DOI: 10.1007/s00125-012-2526-0 PMID: 22476948
68. Hursting SD et al (2010) Calories and carcinogenesis: lessons learned from 30 years of calorie restriction research Carcinogenesis 31(1) 83-9 DOI: 10.1093/carcin/bgp280
69. Longo VD and Fontana L (2010) Calorie restriction and cancer prevention: metabolic and molecular mechanisms Trends Pharmacol Sci 31(2) 89-8 DOI: 10.1016/j.tips.2009.11.004 PMID: 20097433 PMCID: 2829867
70. Levine ME et al (2014) Low protein intake is associated with a major reduction in IGF-1, cancer, and overall mortality in the 65 and younger but not older population Cell Metab 19(3) 407-17 DOI: 10.1016/j.cmet.2014.02.006 PMID: 24606898 PMCID: 3988204
71. Hardie DG (2013) AMPK: a target for drugs and natural products with effects on both diabetes and cancer Diabetes 62(7) 2164-72 DOI: 10.2337/db13-0368 PMID: 23801715 PMCID: 3712072
72. Hardie DG (2014) AMPK - sensing energy while talking to other signaling pathways Cell Metab 20(6) 939-52 DOI: 10.1016/j.cmet.2014.09.013 PMID: 25448702
73. Shackelford DB and Shaw RJ (2009) The LKB1-AMPK pathway: metabolism and growth control in tumour suppression Nat Rev Cancer 9(8) 563-75 DOI: 10.1038/nrc2676 PMID: 19629071 PMCID: 2756045
74. Zhou G et al (2001) Role of AMP-activated protein kinase in mechanism of metformin action J Clin Invest 108(8) 1167-74 DOI: 10.1172/JCI13505 PMID: 11602624 PMCID: 209533
75. Foretz M et al (2010) Metformin inhibits hepatic gluconeogenesis in mice independently of the LKB1/AMPK pathway via a decrease in hepatic energy state J Clin Invest 120(7) 2355-69 DOI: 10.1172/JCI40671 PMID: 20577053 PMCID: 2898585
76. Gandini S et al (2014) Metformin and cancer risk and mortality: a systematic review and meta-analysis taking into account biases and confounders Cancer Prev Res 7(9) 867-85 DOI: 10.1158/1940-6207.CAPR-13-0424
77. Decensi A et al (2010) Metformin and cancer risk in diabetic patients: a systematic review and meta-analysis Cancer Prev Res (Phila) 3(11) 1451-61 DOI: 10.1158/1940-6207.CAPR-10-0157
78. Suissa S and Azoulay L (2012) Metformin and the risk of cancer: time-related biases in observational studies Diabetes Care 35(12) 2665-73 DOI: 10.2337/dc12-0788 PMID: 23173135 PMCID: 3507580
79. Pollak MN (2012) Investigating metformin for cancer prevention and treatment: the end of the beginning. Cancer Discov 2(9) 778-90 DOI: 10.1158/2159-8290.CD-12-0263 PMID: 22926251
80. Gravel SP et al (2014) Serine deprivation enhances antineoplastic activity of biguanides Cancer Res 74(24) 7521-33, DOI: 10.1158/0008-5472.CAN-14-2643-T PMID: 25377470
81. VanSaun MN (2013) Molecular pathways: adiponectin and leptin signaling in cancer Clin Cancer Res 19 1926-32, DOI: 10.1158/1078-0432.CCR-12-0930 PMID: 23355630 PMCID: 3630242
82. Park J and Scherer PE (2012) Adipocyte-derived endotrophin promotes malignant tumor progression J Clin Invest 122(11) 4243-56 DOI: 10.1172/JCI63930 PMID: 23041627 PMCID: 3484450
83. Gregor MF and Hotamisligil GS (2011) Inflammatory mechanisms in obesity Annu Rev Immunol 29 415-45 DOI: 10.1146/annurevimmunol-031210-101322 PMID: 21219177
84. Karin M and Greten FR (2005) NF-kappaB: linking inflammation and immunity to cancer development and progression Nat Rev Immunol 5 (10) 749-59 DOI: 10.1038/nri1703 PMID: 16175180
85. Mirza RE and Koh TJ (2015) Contributions of cell subsets to cytokine production during normal and impaired wound healing Cytokine 71(2) 409-12 DOI: 10.1016/j.cyto.2014.09.005
86. Taniguchi K and Karin M (2014) IL-6 and related cytokines as the critical lynchpins between inflammation and cancer Semin Immunol 26(1) 54-74 DOI: 10.1016/j.smim.2014.01.001 PMID: 24552665
87. Grivennikov S et al (2009) IL-6 and Stat3 are required for survival of intestinal epithelial cells and development of colitis-associated cancer Cancer Cell 15(2) 103-13 DOI: 10.1016/j.ccr.2009.01.001 PMID: 19185845 PMCID: 2667107
88. Park EJ et al (2010) Dietary and genetic obesity promote liver inflammation and tumorigenesis by enhancing IL-6 and TNF expression Cell 140(2) 197-208 DOI: 10.1016/j.cell.2009.12.052 PMID: 20141834 PMCID: 2836922
89. Bäckhed F et al (2004) The gut microbiota as an environmental factor that regulates fat storage Proc Natl Acad Sci USA 101(44) 15718-23 DOI: 10.1073/pnas.0407076101
90. Alang N and Kelly CR Weight gain after fecal microbiota transplantation Open Forum Infect Dis 2(1) DOI: 10.1093/ofid/ofv004 (2015). PMID: 26034755 PMCID: 4438885
91. Schulz MD et al (2014) High-fat-diet-mediated dysbiosis promotes intestinal carcinogenesis independently of obesity Nature 514(7523) 508-12 DOI: 10.1038/nature13398 PMID: 25174708 PMCID: 4233209
92. Yoshimoto S et al (2013) Obesity-induced gut microbial metabolite promotes liver cancer through senescence secretome Nature 499(7456) 97-101, http://www.nature.com/nature/journal/v499/n7456/abs/nature12347.html - supplementary-information DOI: 10.1038/nature12347 PMID: 23803760
93. Han PY et al (2007) Dosing in obesity: a simple solution to a big problem Clin Pharmacol Ther 82(5) 505-8 DOI: 10.1038/sj.clpt.6100381 PMID: 17952107
94. Mathijssen RHJ and Sparreboom A (2009) Influence of lean body weight on anticancer drug clearance Clinical Pharmacol Ther 85(1) 23 DOI: 10.1038/sj.clpt.6100511
95. Lyman GH and Sparreboom A (2013) Chemotherapy dosing in overweight and obese patients with cancer Nat Rev Clin Oncol 10(8) 451-9 DOI: 10.1038/nrclinonc.2013.108 PMID: 23856744
96. Colleoni M et al (2005) Relation between chemotherapy dose, oestrogen receptor expression, and body-mass index Lancet 366(9491) 1108-10 DOI: 10.1016/S0140-6736(05)67110-3 PMID: 16182899
97. Ladoire S et al (2014) Effect of obesity on disease-free and overall survival in node-positive breast cancer patients in a large French population: a pooled analysis of two randomised trials Eur J Cancer 50(3) 506-16 DOI: 10.1016/j.ejca.2013.11.013
98. Fontanella C et al (2015) Impact of body mass index on neoadjuvant treatment outcome: a pooled analysis of eight prospective neoadjuvant breast cancer trials Breast Cancer Res Treat 150(1) 127-39 DOI: 10.1007/s10549-015-3287-5 PMID: 25677740
99. Griggs JJ et al Appropriate chemotherapy dosing for obese adult patients with cancer: American Society of Clinical Oncology clinical practice guideline J Clin Oncol 30(13) 1553-61 DOI: 10.1200/jco.2011.39.9436 PMID: 22473167
100. Casagrande DS et al (2014) Incidence of cancer following bariatric surgery: systematic review and meta-analysis Obes Surg 24(9) 1499-1509 DOI: 10.1007/s11695-014-1276-0 PMID: 24817500
101. Franco M et al (2013) Population-wide weight loss and regain in relation to diabetes burden and cardiovascular mortality in Cuba 1980-2010 repeated cross sectional surveys and ecological comparison of secular trends BMJ 346 f1515 DOI: 10.1136/bmj.f1515
102. Pierce JP et al (2007) Influence of a diet very high in vegetables, fruit, and fiber and low in fat on prognosis following treatment for breast cancer: the Women's Healthy Eating and Living (WHEL) randomized trial JAMA 298(3) 289-98 DOI: 10.1001/jama.298.3.289 PMID: 17635889 PMCID: 2083253
103. Chlebowski RT et al (2006) Dietary Fat Reduction and Breast Cancer Outcome: Interim Efficacy Results From the Women's Intervention Nutrition Study J Natl Cancer Inst 98(24) 1767-76 DOI: 10.1093/jnci/djj494 PMID: 17179478
104. Johnston BC et al (2014) Comparison of weight loss among named diet programs in overweight and obese adults: A meta-analysis JAMA 312(9) 923-33 DOI: 10.1001/jama.2014.10397 PMID: 25182101
105. Orlich MJ et al (2015) Vegetarian dietary patterns and the risk of colorectal cancers JAMA Intern Med 175(5) 767-76 DOI: 10.1001/jamainternmed.2015.59 PMID: 25751512 PMCID: 4420687
106. Key TJ et al (2009) Cancer incidence in British vegetarians Br J Cancer 101(1) 192-7 DOI: 10.1038/sj.bjc.6605098 PMID: 19536095 PMCID: 2699384
107. Key TJ et al (2009) Cancer incidence in vegetarians: results from the European Prospective Investigation into Cancer and Nutrition (EPIC-Oxford) Am J Clin Nutr 89(5) 1620S-1626S DOI: 10.3945/ajcn.2009.26736M PMID: 19279082
108. Kalaany NY and Sabatini DM (2009) Tumours with PI3K activation are resistant to dietary restriction Nature 458 (7239) 725-31 DOI: 10.1038/nature07782 PMID: 19279572 PMCID: 2692085
109. Reeves MM et al (2014) Weight loss intervention trials in women with breast cancer: a systematic review Obes Rev 15(9) 749-68 DOI: 10.1111/obr.12190 PMID: 24891269